Merck KGaA May Divest Generics

19:37 PM | January 10, 2007 | Chemical Week Editorial Staff

Merck KGaA is considering plans to divest its generic drugs business and could raise up to €4 billion ($5.3 billion) from the sale, according to a report in German newspaper Handelsblatt on January 4...